Welcome to our dedicated page for Nextgen Healthcare news (Ticker: NXGN), a resource for investors and traders seeking the latest updates and insights on Nextgen Healthcare stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nextgen Healthcare's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nextgen Healthcare's position in the market.
NextGen Healthcare, Inc. (Nasdaq: NXGN) reported fiscal second quarter results for 2022, showing total revenue of $149.3 million, a 7% increase year-over-year. Recurring revenue comprised 91% of this, totaling $135.6 million, up 8%. Subscription services revenue rose 12% to $41.1 million. Despite a net loss per share of $0.10, the company adjusted its 2022 revenue guidance to between $584 and $590 million. Positive earnings guidance was also raised to between $0.90 and $0.96 per share.
NextGen Healthcare (NASDAQ: NXGN) partners with Validic to enhance patient care through real-time remote patient monitoring (RPM). White House Clinics in Kentucky, utilizing NextGen's integrated digital health platform, leverages RPM for chronic-condition management, improving patient engagement and care insights. The solution streamlines data from various devices, facilitating better clinical decision-making. NextGen's technology suite includes EHR, practice management, and patient experience tools, enabling comprehensive healthcare delivery.
NextGen Healthcare, Inc. (NASDAQ: NXGN) will host its 24th annual User Group Meeting (UGM) virtually from November 8-10, 2021. The event, themed “Engage,” aims to provide insights and trends affecting ambulatory practices. Keynote presentations will be delivered by
NextGen Healthcare, Inc. (NASDAQ: NXGN) will release its fiscal 2022 Q2 operating results on October 28, 2021, post-market. A conference call will follow at 5:00 p.m. ET, where shareholders can join via phone. This quarterly result marks an important update for investors, reflecting the company's performance in the ambulatory technology sector.
NextGen is a leader in providing technology solutions for ambulatory care, focusing on improving clinical productivity and financial outcomes.
NextGen Healthcare, Inc. (NASDAQ: NXGN) held its 2021 Annual Meeting, where founder Sheldon Razin expressed gratitude towards shareholders for their engagement. He highlighted the company's growth and market expansion, crediting the dedication of the team and the recent appointment of new CEO David Sides. Razin emphasized that NextGen Healthcare is well-positioned to continue its leadership in the ambulatory care market, supported by its impressive portfolio of products and services.
NextGen Healthcare, Inc. (Nasdaq: NXGN) announced significant outcomes from its Annual Meeting. Shareholders approved the company's reincorporation into Delaware, eliminated cumulative voting in director elections, and elected all nine director nominees. The Board now includes eight independent directors and a new CEO, enhancing diversity and expertise. Additionally, shareholders ratified the appointment of the accounting firm and amended the equity plan. However, proposals regarding executive compensation and Board authority increase were not approved. Results will be filed with the SEC.
NextGen Healthcare, Inc. (NASDAQ: NXGN) has partnered with the Community Health Center of Snohomish County in Washington to implement its comprehensive technology solutions. The adoption includes NextGen Enterprise EHR, PM, and Population Health solutions to enhance healthcare services for nearly 70,000 annual patients. The clinic aims to improve productivity, simplify billing, and expand access to care, especially for underserved populations. The integrated platform supports complex healthcare requirements, enabling the clinic to enhance patient engagement and service delivery.
NextGen Healthcare (NXGN) encourages shareholders to vote 'FOR' its nominated directors and proposals on the WHITE proxy card for the upcoming Annual Meeting on October 13, 2021. The company has received endorsements from three prominent proxy advisory firms: ISS, Glass Lewis, and Egan-Jones. The Board highlights significant transformations under new leadership, emphasizing enhanced capital allocation towards R&D and strategic M&A, resulting in an improved management team and boosted employee engagement. The firm reports accelerating revenue growth and strong operating cash flow with no debt.
NextGen Healthcare, Inc. (Nasdaq: NXGN) has expanded its collaboration with Mednax, Inc., enhancing its integrated healthcare platform. Mednax will now utilize NextGen Virtual Visits™ and NextGen® Mobile to streamline patient care. This integration supports over 800 ambulatory providers across 39 states, facilitating efficient workflows and improving patient experiences.
The Razin Group, representing 15.2% of NextGen Healthcare (NXGN) shares, advocates for the election of a new board slate during the Annual Meeting on October 13, 2021. The group criticizes the current board's six years of underperformance under Chairman Jeffrey Margolis, noting a lack of significant growth despite repeated promises. They urge shareholders to vote on the BLUE Proxy Card to reset the board's power dynamics, emphasizing the importance of board members having meaningful equity stakes for accountability and better governance.